334 related articles for article (PubMed ID: 23804551)
1. Residual shunting after percutaneous PFO closure: how to manage and how to close.
Butera G; Sarabia JF; Saracino A; Chessa M; Piazza L; Carminati M
Catheter Cardiovasc Interv; 2013 Nov; 82(6):950-8. PubMed ID: 23804551
[TBL] [Abstract][Full Text] [Related]
2. Management of residual shunts after initial percutaneous patent foramen ovale closure: a single center experience with immediate and long-term follow-up.
Diaz T; Cubeddu RJ; Rengifo-Moreno PA; Cruz-Gonzalez I; Solis-Martin J; Buonanno FS; Inglessis I; Palacios IF
Catheter Cardiovasc Interv; 2010 Jul; 76(1):145-50. PubMed ID: 20578100
[TBL] [Abstract][Full Text] [Related]
3. Initial experience with the novel patent foramen ovale occlusion device Nit-Occlud® in patients with stroke or transient ischemic attack.
Steinberg DH; Bertog SC; Momberger J; Franke J; Hofmann I; Renkhoff K; Joy S; Vaskelyte L; Sievert H
Catheter Cardiovasc Interv; 2015 Jun; 85(7):1262-7. PubMed ID: 24948394
[TBL] [Abstract][Full Text] [Related]
4. Predictors of recurrent events in patients with cryptogenic stroke and patent foramen ovale within the CLOSURE I (Evaluation of the STARFlex Septal Closure System in Patients With a Stroke and/or Transient Ischemic Attack Due to Presumed Paradoxical Embolism Through a Patent Foramen Ovale) trial.
Elmariah S; Furlan AJ; Reisman M; Burke D; Vardi M; Wimmer NJ; Ling S; Chen X; Kent DM; Massaro J; Mauri L;
JACC Cardiovasc Interv; 2014 Aug; 7(8):913-20. PubMed ID: 25147037
[TBL] [Abstract][Full Text] [Related]
5. Transcatheter PFO closure with GORE(®) septal occluder: early and mid-term clinical results.
Butera G; Saracino A; Danna P; Sganzerla P; Chessa M; Carminati M
Catheter Cardiovasc Interv; 2013 Nov; 82(6):944-9. PubMed ID: 23897659
[TBL] [Abstract][Full Text] [Related]
6. Long-term follow-up after PFO device closure: Outcomes and Complications in a Single-center Experience.
Taggart NW; Reeder GS; Lennon RJ; Slusser JP; Freund MA; Cabalka AK; Cetta F; Hagler DJ
Catheter Cardiovasc Interv; 2017 Jan; 89(1):124-133. PubMed ID: 27027873
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of different devices for transcatheter closure of patent foramen ovale assessed by serial transoesophageal echocardiography and rates of recurrent cerebrovascular events in a long-term follow-up.
Luani B; Markovic S; Krumsdorf U; Rottbauer W; Wöhrle J
EuroIntervention; 2015 May; 11(1):85-91. PubMed ID: 25572024
[TBL] [Abstract][Full Text] [Related]
8. Residual shunt after percutaneous closure of patent foramen ovale with AMPLATZER occluder devices - influence of anatomic features: a transcranial Doppler and intracardiac echocardiography study.
Marchese N; Pacilli MA; Inchingolo V; Fanelli R; Loperfido F; Vigna C
EuroIntervention; 2013 Jul; 9(3):382-8. PubMed ID: 23872652
[TBL] [Abstract][Full Text] [Related]
9. Residual Shunt after Patent Foramen Ovale Device Closure in Patients With Cryptogenic Stroke: Serial Bubble Contrast Transesophageal Echocardiography Data.
Moon J; Kim M; Oh PC; Shin DH; Park HM; Jo YY; Lee JS; Kang WC
J Stroke Cerebrovasc Dis; 2019 Feb; 28(2):347-353. PubMed ID: 30396838
[TBL] [Abstract][Full Text] [Related]
10. Percutaneous patent foramen ovale closure: outcomes with the Premere and Amplatzer devices.
Bissessor N; Wong AW; Hourigan LA; Jayasinghe RS; Scalia GS; Burstow DJ; Griffiths LR; Savage M; Walters DL
Cardiovasc Revasc Med; 2011; 12(3):164-169. PubMed ID: 21640934
[TBL] [Abstract][Full Text] [Related]
11. Figulla PFO occluder versus Amplatzer PFO occluder for percutaneous closure of patent foramen ovale.
Saguner AM; Wahl A; Praz F; de Marchi SF; Mattle HP; Cook S; Windecker S; Meier B
Catheter Cardiovasc Interv; 2011 Apr; 77(5):709-14. PubMed ID: 20931665
[TBL] [Abstract][Full Text] [Related]
12. The Flatstent versus the conventional umbrella devices in the percutaneous closure of patent foramen ovale.
Aral M; Mullen M
Catheter Cardiovasc Interv; 2015 May; 85(6):1058-65. PubMed ID: 25413379
[TBL] [Abstract][Full Text] [Related]
13. Comparison of residual shunt rates in five devices used to treat patent foramen ovale.
Matsumura K; Gevorgyan R; Mangels D; Masoomi R; Mojadidi MK; Tobis J
Catheter Cardiovasc Interv; 2014 Sep; 84(3):455-63. PubMed ID: 24550064
[TBL] [Abstract][Full Text] [Related]
14. Clinical outcomes of patent foramen ovale closure for paradoxical emboli without echocardiographic guidance.
Varma C; Benson LN; Warr MR; Yeo E; Yip J; Jaigobin CS; Webb G; McLaughlin PR
Catheter Cardiovasc Interv; 2004 Aug; 62(4):519-25. PubMed ID: 15274165
[TBL] [Abstract][Full Text] [Related]
15. Coil closure of residual shunt after Amplatzer PFO occlusion.
Meier B
Catheter Cardiovasc Interv; 2011 Apr; 77(5):720-1. PubMed ID: 20939039
[TBL] [Abstract][Full Text] [Related]
16. Medium-term results of transcatheter closure of patent foramen ovale (PFO) with Amplatzer PFO and Cribriform occluders.
Białkowski J; Wawrzyńczyk M; Karwot B; Fiszer R; Knop M; Szkutnik M
Kardiol Pol; 2012; 70(11):1142-6. PubMed ID: 23180522
[TBL] [Abstract][Full Text] [Related]
17. Percutaneous closure of patent foramen ovale with a bioabsorbable occluder device: single-centre experience.
Ussia GP; Cammalleri V; Mulè M; Scarabelli M; Barbanti M; Scardaci F; Mangiafico S; Immè S; Capodanno D; Tamburino C
Catheter Cardiovasc Interv; 2009 Oct; 74(4):607-14. PubMed ID: 19360875
[TBL] [Abstract][Full Text] [Related]
18. Interventional closure of patent foramen ovale with Nit-occlud® device in prevention of recurrent neurologic events-Long-term results.
Araszkiewicz A; Sławek S; Trojnarska O; Lesiak M; Grygier M
Catheter Cardiovasc Interv; 2018 Jul; 92(1):159-164. PubMed ID: 29068141
[TBL] [Abstract][Full Text] [Related]
19. PFO "angioplasty": The preparation of a very stiff and long tunnel for device closure.
Butera G; Piazza L; Heles M
Catheter Cardiovasc Interv; 2017 Feb; 89(3):480-483. PubMed ID: 27515784
[TBL] [Abstract][Full Text] [Related]
20. Risk of recurrent cerebrovascular events in patients with cryptogenic stroke or transient ischemic attack and patent foramen ovale: the FORI (Foramen Ovale Registro Italiano) study.
Paciaroni M; Agnelli G; Bertolini A; Pezzini A; Padovani A; Caso V; Venti M; Alberti A; Palmiero RA; Cerrato P; Silvestrelli G; Lanari A; Previdi P; Corea F; Balducci A; Ferri R; Falcinelli F; Filippucci E; Chiocchi P; Grandi FC; Ferigo L; Musolino R; Bersano A; Ghione I; Sacco S; Carolei A; Baldi A; Ageno W;
Cerebrovasc Dis; 2011; 31(2):109-16. PubMed ID: 21088390
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
